Silverarc Capital Management, LLC Renalytix PLC Transaction History

Silverarc Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$13.43 - $27.4 $496,910 - $1.01 Million	-37,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$17.91 - $34.78 $1.6 Million - $3.1 Million	-89,145 Reduced 70.67%	37,000 $742,000
Q2 2021 Aug 16, 2021	SELL	$23.56 - $34.25 $198,139 - $288,042	-8,410 Reduced 6.25%	126,145 $3.89 Million
Q1 2021 May 18, 2021	SELL	$15.25 - $31.13 $102,144 - $208,508	-6,698 Reduced 4.74%	134,555 $3.45 Million
Q4 2020 Feb 16, 2021	BUY	$10.69 - $16.0 $1.51 Million - $2.26 Million	141,253 New	141,253 $2.26 Million

554K

Ticker RNLX
Exchange OTC
Sector Healthcare
Industry Health Information Services
Shares Outstandng 37,445,900
Market Cap $5.62M
Description
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.